The Effectiveness of Laserpuncture on Chemotherapy-induced Leucopenia in Head and Neck Cancer Patients

The goal of this clinical trial is to evaluate if laserpuncture (laser acupuncture) can reduce leucopenia caused by chemotherapy and improve the quality of life in patients with head and neck cancer. The main questions it aims to answer are: * Does laserpuncture reduce the incidence of chemotherapy-induced Leucopenia ? * Does laserpuncture improve quality of life in these patients? Researchers will compare patients receiving laserpuncture therapy to a control group receiving sham laserpuncture to see if the intervention has a beneficial effect. Participants will: * Undergo six sessions of laserpunktur or sham laserpuncture during chemotherapy * Have leukocyte counts and absolute neutrophil counts measured before and 7-14 days after chemotherapy * Complete quality of life assessments using EORTC QLQ-C30 and EORTC QLQ-H\&N35 questionnaires

NCT Number	NCT07075809
Lead Sponsor	Indonesia University
Conditions	Leucopenia Induced Chemoteraphy Adult
Enrollment	30 participants
Start Date	2025-10-01
Primary Completion	2025-12-12 (estimated)
Study Completion	2025-12-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-05